Tag: low tumor burden follicular lymphoma

No clinical benefit of specific immunotherapy seen in lymphoma

Prolonged rituximab maintenance therapy does not provide overall survival benefit in low-burden follicular lymphoma

byVanessa Giulianoand1 others

January 28, 2024

1. In patients with low tumor burden follicular lymphoma (LTBFL): Rituximab maintenance therapy does not improve overall survival in comparison ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result